0
     

Report Added
Report already added
Anti-inflammatory Therapeutics Market in India - Industry Outlook and Forecast 2020-2026

Anti-inflammatory Therapeutics Market in India - Industry Outlook and Forecast 2020-2026

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

This report contains market size and forecasts of Anti-inflammatory Therapeutics in India, including the following market information:
India Anti-inflammatory Therapeutics Market Revenue, 2015-2020, 2021-2026, ($ millions)
Top Five Competitors in India Anti-inflammatory Therapeutics Market 2019 (%)
The global Anti-inflammatory Therapeutics market was valued at 100870 million in 2019 and is projected to reach US$ 126610 million by 2026, at a CAGR of 5.8% during the forecast period. While the Anti-inflammatory Therapeutics market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
COVID-19 pandemic has big impact on Anti-inflammatory Therapeutics businesses, with lots of challenges and uncertainty faced by many players of Anti-inflammatory Therapeutics in India. This report also analyses and evaluates the COVID-19 impact on Anti-inflammatory Therapeutics market size in 2020 and the next few years in India
Total Market by Segment:
India Anti-inflammatory Therapeutics Market, By Type, 2015-2020, 2021-2026 ($ millions)
India Anti-inflammatory Therapeutics Market Segment Percentages, By Type, 2019 (%)
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
On the basis of product type, anti-inflammatory biologics segment is projected to account for the largest revenue share during the forecast period; this segment was estimated to account for 58.35% revenue share in 2019, at a cagr of 6.54% in the forecast period.

India Anti-inflammatory Therapeutics Market, By Application, 2015-2020, 2021-2026 ($ millions)
India Anti-inflammatory Therapeutics Market Segment Percentages, By Application, 2019 (%)
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Arthritis accounted for over 42.41% global revenue share in 2019. And it is also show a fast growth rate of 6.60% in the next few years from 2020 to 2026.

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Anti-inflammatory Therapeutics Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)
Total Anti-inflammatory Therapeutics Market Competitors Revenues Share in India, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
1 Introduction to Research & Analysis Reports
1.1 Anti-inflammatory Therapeutics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 COVID-19 Impact: India Anti-inflammatory Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 India Anti-inflammatory Therapeutics Overall Market Size
2.1 India Anti-inflammatory Therapeutics Market Size: 2020 VS 2026
2.2 India Anti-inflammatory Therapeutics Revenue, Prospects & Forecasts: 2015-2026

3 Company Landscape
3.1 Top Anti-inflammatory Therapeutics Players in India (including Foreign and Local Companies)
3.2 Top India Anti-inflammatory Therapeutics Companies Ranked by Revenue
3.3 India Anti-inflammatory Therapeutics Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Anti-inflammatory Therapeutics Companies in India, by Revenue in 2019
3.5 India Manufacturers Anti-inflammatory Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-inflammatory Therapeutics Players in India
3.6.1 List of India Tier 1 Anti-inflammatory Therapeutics Companies
3.6.2 List of India Tier 2 and Tier 3 Anti-inflammatory Therapeutics Companies

4 Sights by Product
4.1 Overview
4.1.1 By Type - India Anti-inflammatory Therapeutics Market Size Markets, 2020 & 2026
4.1.2 Anti-inflammatory Biologics
4.1.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
4.1.4 Corticosteroids
4.1.5 Others
4.2 By Type - India Anti-inflammatory Therapeutics Revenue & Forecasts
4.2.1 By Type - India Anti-inflammatory Therapeutics Revenue, 2015-2020
4.2.2 By Type - India Anti-inflammatory Therapeutics Revenue, 2021-2026
4.2.3 By Type - India Anti-inflammatory Therapeutics Revenue Market Share, 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - India Anti-inflammatory Therapeutics Market Size, 2020 & 2026
5.1.2 Arthritis
5.1.3 Respiratory Diseases
5.1.4 Dermatology
5.1.5 Gastroenterology
5.1.6 Others
5.2 By Application - India Anti-inflammatory Therapeutics Revenue & Forecasts
5.2.1 By Application - India Anti-inflammatory Therapeutics Revenue, 2015-2020
5.2.2 By Application - India Anti-inflammatory Therapeutics Revenue, 2021-2026
5.2.3 By Application - India Anti-inflammatory Therapeutics Revenue Market Share, 2015-2026
6 Players Profiles
6.1 AbbVie
6.1.1 AbbVie Corporate Summary
6.1.2 AbbVie Business Overview
6.1.3 AbbVie Anti-inflammatory Therapeutics Major Product Offerings
6.1.4 AbbVie Revenue in India (2015-2020)
6.1.5 AbbVie Key News
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporate Summary
6.2.2 Johnson & Johnson Business Overview
6.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Major Product Offerings
6.2.4 Johnson & Johnson Revenue in India (2015-2020)
6.2.5 Johnson & Johnson Key News
6.3 Amgen Inc
6.3.1 Amgen Inc Corporate Summary
6.3.2 Amgen Inc Business Overview
6.3.3 Amgen Inc Anti-inflammatory Therapeutics Major Product Offerings
6.3.4 Amgen Inc Revenue in India (2015-2020)
6.3.5 Amgen Inc Key News
6.4 AstraZeneca PLC
6.4.1 AstraZeneca PLC Corporate Summary
6.4.2 AstraZeneca PLC Business Overview
6.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Major Product Offerings
6.4.4 AstraZeneca PLC Revenue in India (2015-2020)
6.4.5 AstraZeneca PLC Key News
6.5 Pfizer, Inc
6.5.1 Pfizer, Inc Corporate Summary
6.5.2 Pfizer, Inc Business Overview
6.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Major Product Offerings
6.5.4 Pfizer, Inc Revenue in India (2015-2020)
6.5.5 Pfizer, Inc Key News
6.6 Novartis
6.6.1 Novartis Corporate Summary
6.6.2 Novartis Business Overview
6.6.3 Novartis Anti-inflammatory Therapeutics Major Product Offerings
6.6.4 Novartis Revenue in India (2015-2020)
6.6.5 Novartis Key News
6.7 Roche
6.6.1 Roche Corporate Summary
6.6.2 Roche Business Overview
6.6.3 Roche Anti-inflammatory Therapeutics Major Product Offerings
6.4.4 Roche Revenue in India (2015-2020)
6.7.5 Roche Key News
6.8 Merck
6.8.1 Merck Corporate Summary
6.8.2 Merck Business Overview
6.8.3 Merck Anti-inflammatory Therapeutics Major Product Offerings
6.8.4 Merck Revenue in India (2015-2020)
6.8.5 Merck Key News
6.9 Sanofi
6.9.1 Sanofi Corporate Summary
6.9.2 Sanofi Business Overview
6.9.3 Sanofi Anti-inflammatory Therapeutics Major Product Offerings
6.9.4 Sanofi Revenue in India (2015-2020)
6.9.5 Sanofi Key News
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporate Summary
6.10.2 GlaxoSmithKline Business Overview
6.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Major Product Offerings
6.10.4 GlaxoSmithKline Revenue in India (2015-2020)
6.10.5 GlaxoSmithKline Key News
6.11 Sun Pharmaceutical Industries Ltd
6.11.1 Sun Pharmaceutical Industries Ltd Corporate Summary
6.11.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Business Overview
6.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Major Product Offerings
6.11.4 Sun Pharmaceutical Industries Ltd Revenue in India (2015-2020)
6.11.5 Sun Pharmaceutical Industries Ltd Key News
6.12 TEVA
6.12.1 TEVA Corporate Summary
6.12.2 TEVA Anti-inflammatory Therapeutics Business Overview
6.12.3 TEVA Anti-inflammatory Therapeutics Major Product Offerings
6.12.4 TEVA Revenue in India (2015-2020)
6.12.5 TEVA Key News

7 Key Market Trends & Influences 2021-2026
7.1 PESTLE Analysis for India Anti-inflammatory Therapeutics Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints

8 Conclusion

9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Key Players of Anti-inflammatory Therapeutics in India
Table 2. Top Players in India, Ranking by Revenue (2019)
Table 3. India Anti-inflammatory Therapeutics Revenue by Companies, (US$, Mn), 2015-2020
Table 4. India Anti-inflammatory Therapeutics Revenue Share by Companies, 2015-2020
Table 5. India Anti-inflammatory Therapeutics Sales by Companies, (K Units), 2015-2020
Table 6. India Anti-inflammatory Therapeutics Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Anti-inflammatory Therapeutics Price (2015-2020) (US$/Unit)
Table 8. India Manufacturers Anti-inflammatory Therapeutics Product Type
Table 9. List of India Tier 1 Anti-inflammatory Therapeutics Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of India Tier 2 and Tier 3 Anti-inflammatory Therapeutics Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Anti-inflammatory Therapeutics Revenue in India (US$, Mn), 2015-2020
Table 12. By Type - Anti-inflammatory Therapeutics Revenue in India (US$, Mn), 2021-2026
Table 13. By Type - Anti-inflammatory Therapeutics Sales in India (K Units), 2015-2020
Table 14. By Type - Anti-inflammatory Therapeutics Sales in India (K Units), 2021-2026
Table 15. By Application - Anti-inflammatory Therapeutics Revenue in India, (US$, Mn), 2015-2020
Table 16. By Application - Anti-inflammatory Therapeutics Revenue in India, (US$, Mn), 2021-2026
Table 17. By Application - Anti-inflammatory Therapeutics Sales in India, (K Units), 2015-2020
Table 18. By Application - Anti-inflammatory Therapeutics Sales in India, (K Units), 2021-2026
Table 19. AbbVie Corporate Summary
Table 20. AbbVie Anti-inflammatory Therapeutics Product Offerings
Table 21. AbbVie Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 22. Johnson & Johnson Corporate Summary
Table 23. Johnson & Johnson Anti-inflammatory Therapeutics Product Offerings
Table 24. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 25. Amgen Inc Corporate Summary
Table 26. Amgen Inc Anti-inflammatory Therapeutics Product Offerings
Table 27. Amgen Inc Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 28. AstraZeneca PLC Corporate Summary
Table 29. AstraZeneca PLC Anti-inflammatory Therapeutics Product Offerings
Table 30. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 31. Pfizer, Inc Corporate Summary
Table 32. Pfizer, Inc Anti-inflammatory Therapeutics Product Offerings
Table 33. Pfizer, Inc Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 34. Novartis Corporate Summary
Table 35. Novartis Anti-inflammatory Therapeutics Product Offerings
Table 36. Novartis Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 37. Roche Corporate Summary
Table 38. Roche Anti-inflammatory Therapeutics Product Offerings
Table 39. Roche Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 40. Merck Corporate Summary
Table 41. Merck Anti-inflammatory Therapeutics Product Offerings
Table 42. Merck Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 43. Sanofi Corporate Summary
Table 44. Sanofi Anti-inflammatory Therapeutics Product Offerings
Table 45. Sanofi Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Anti-inflammatory Therapeutics Product Offerings
Table 48. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 49. Sun Pharmaceutical Industries Ltd Corporate Summary
Table 50. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offerings
Table 51. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
Table 52. TEVA Corporate Summary
Table 53. TEVA Anti-inflammatory Therapeutics Product Offerings
Table 54. TEVA Anti-inflammatory Therapeutics Revenue (US$, Mn), (2015-2020)
List of Figures
Figure 1. Anti-inflammatory Therapeutics Segment by Type
Figure 2. Anti-inflammatory Therapeutics Segment by Application
Figure 3. India Anti-inflammatory Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Anti-inflammatory Therapeutics Market Size in India, (US$, Mn): 2020 VS 2026
Figure 6. India Anti-inflammatory Therapeutics Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2019
Figure 8. By Type - India Anti-inflammatory Therapeutics Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - India Anti-inflammatory Therapeutics Market Share, 2015-2026
Figure 10. By Application - Anti-inflammatory Therapeutics Revenue in India (US$, Mn), 2020 & 2026
Figure 11. By Application - India Anti-inflammatory Therapeutics Market Share, 2015-2026
Figure 12. PEST Analysis for India Anti-inflammatory Therapeutics Market in 2020
Figure 13. Anti-inflammatory Therapeutics Market Opportunities & Trends in India
Figure 14. Anti-inflammatory Therapeutics Market Drivers in India

Report Title: Anti-inflammatory Therapeutics Market in India - Industry Outlook and Forecast 2020-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW